# Autologous Culture Expanded Adipose Derived MSCs for Treatment of Painful Hip OA

> **NCT03608579** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Mayo Clinic** · enrollment: 24 (actual)

## Conditions studied

- Osteoarthritis, Hip

## Interventions

- **DRUG:** Autologous Adipose Derived Mesenchymal Stromal Cells

## Key facts

- **NCT ID:** NCT03608579
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-11-05
- **Primary completion:** 2026-10
- **Final completion:** 2026-12
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03608579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03608579, "Autologous Culture Expanded Adipose Derived MSCs for Treatment of Painful Hip OA". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03608579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*